Last updated on February 2019

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

Brief description of study

Prospective randomized study comparing different colistin dosing regimens in paediatric cancer patient with MDR gram-negative infection or sepsis

Detailed Study Description

The aim of this study is to:

  1. Evaluate the clinical outcome of two different dosing regimen of IV colistin in the treatment of children with multidrug resistant gram-negative infections or sepsis.
  2. To estimate the frequency of colistin associated adverse effects.
  3. To correlate the serum colistin concentration and MIC to microbiological clearance and clinical outcome

Clinical Study Identifier: NCT03397914

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.